Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.
about
Ligand-targeted theranostic nanomedicines against cancerIntegrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releasePromiscuous tumor targeting phage proteins.The oncolytic peptide LTX-315 triggers necrotic cell death.Activated α2-Macroglobulin Regulates Transcriptional Activation of c-MYC Target Genes through Cell Surface GRP78 Protein.Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.Prostate cancer and the unfolded protein response.Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect.Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library.GRP78 and α2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment.
P2860
Q35895637-D077B687-B1C9-4041-AEA5-B6723A4C1128Q35912798-E751751F-4E41-42DD-94CC-88F4B3BD111DQ36581309-BE070418-47E0-42D5-8A6D-3B68E92B9923Q36780793-3CD28831-DF55-4EBF-8346-9F75A0A5BD71Q36898317-AA82DEB8-3F45-4FC0-A6DC-2AE121610596Q37417870-78647F45-B5B4-406E-A077-AFE80A12357CQ37417906-E8CC4E21-3D9C-4066-B6E0-73E6E465AAD8Q37619869-CC9552BC-0100-4F5B-86D3-62E113078AD8Q47096429-D9FF010E-21B0-47FC-8F24-F623474BECC3Q47632555-18D8F8F6-26C6-4850-A90F-FEE6E054DACDQ53834602-8709C58F-5ACE-4A78-866F-605EC0671911
P2860
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Selection and identification o ...... te cancer and their receptors.
@ast
Selection and identification o ...... te cancer and their receptors.
@en
type
label
Selection and identification o ...... te cancer and their receptors.
@ast
Selection and identification o ...... te cancer and their receptors.
@en
prefLabel
Selection and identification o ...... te cancer and their receptors.
@ast
Selection and identification o ...... te cancer and their receptors.
@en
P2093
P2860
P356
P1476
Selection and identification o ...... te cancer and their receptors.
@en
P2093
Andrey S Dobroff
Anna Cecilia Rietz
Bettina Proneth
Christopher J Logothetis
Jami Mandelin
Marina Cardó-Vila
Nora M Navone
Paul Mathew
Richard L Sidman
Sue-Hwa Lin
P2860
P304
P356
10.1073/PNAS.1500128112
P407
P577
2015-03-11T00:00:00Z